PMC:7228307 / 52708-52886
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id | tao:has_standard_notation |
|---|---|---|---|---|---|---|
| 1063 | 62-67 | Gene | denotes | PD‐L1 | Gene:29126 | |
| 1069 | 45-55 | Chemical | denotes | durvalumab | MESH:C000613593 | |
| 1070 | 73-84 | Chemical | denotes | anifrolumab | MESH:C582345 | |
| 1071 | 171-176 | Mutation | denotes | L234F | p.L234F |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T408 | 16-27 | Body_part | denotes | amino acids | http://purl.org/sig/ont/fma/fma82739 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T892 | 62-67 | http://purl.obolibrary.org/obo/CLO_0008407 | denotes | PD‐L1 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T10443 | 16-27 | Chemical | denotes | amino acids | http://purl.obolibrary.org/obo/CHEBI_33709 |
| T57589 | 16-21 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
| T8912 | 22-27 | Chemical | denotes | acids | http://purl.obolibrary.org/obo/CHEBI_37527 |
| T75315 | 62-64 | Chemical | denotes | PD | http://purl.obolibrary.org/obo/CHEBI_74756 |
| T36188 | 91-101 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T58 | 16-27 | Chemical | denotes | amino acids | http://purl.obolibrary.org/obo/CHEBI_33709 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes | pubann:has_HGVS_notation |
|---|---|---|---|---|---|---|
| 1063 | 62-67 | Gene | denotes | PD‐L1 | Gene:29126 | |
| 1069 | 45-55 | Chemical | denotes | durvalumab | MESH:C000613593 | |
| 1070 | 73-84 | Chemical | denotes | anifrolumab | MESH:C582345 | |
| 1071 | 171-176 | Mutation | denotes | L234F | p.L234F |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T300 | 0-178 | Sentence | denotes | The lower hinge amino acids of the IgG1 mAbs durvalumab (anti‐PD‐L1) and anifrolumab (anti‐interferon‐α receptor; Table 4) were modified to mimic the lower hinge of IgG4 (L234F). |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T704 | 62-67 | Protein | denotes | PD‐L1 | https://www.uniprot.org/uniprot/Q9NZQ7|https://www.uniprot.org/uniprot/Q9NUZ5|https://www.uniprot.org/uniprot/Q9EP73|https://www.uniprot.org/uniprot/Q6WEX4|https://www.uniprot.org/uniprot/Q66RK1|https://www.uniprot.org/uniprot/Q2V8D5|https://www.uniprot.org/uniprot/Q14CJ2|https://www.uniprot.org/uniprot/B4DU27|https://www.uniprot.org/uniprot/B2RBA2 |
| T713 | 91-101 | Protein | denotes | interferon | https://www.uniprot.org/uniprot/P51527|https://www.uniprot.org/uniprot/P51526 |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T407 | 16-27 | Body_part | denotes | amino acids | http://purl.org/sig/ont/fma/fma82739 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T300 | 0-178 | Sentence | denotes | The lower hinge amino acids of the IgG1 mAbs durvalumab (anti‐PD‐L1) and anifrolumab (anti‐interferon‐α receptor; Table 4) were modified to mimic the lower hinge of IgG4 (L234F). |